Creon After Pancreatic Surgery
- Registration Number
- NCT00535756
- Lead Sponsor
- Abbott Products
- Brief Summary
This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Placebo - 1 Creon -
- Primary Outcome Measures
Name Time Method Change in CFA from baseline to the end of double blind treatment 7 days after baseline
- Secondary Outcome Measures
Name Time Method CNA, stool fat, stool weight, nutritional parameters, clinical symptomatology, SF-36, BMI 7 days after baseline, and end of open-label period (1 year of open label treatment)
Trial Locations
- Locations (15)
Site Reference ID/Investigator# 45022
🇧🇬Ruse, Bulgaria
Site Reference ID/Investigator# 45020
🇧🇬Sofia, Bulgaria
Site Reference ID/Investigator# 45026
🇩🇪Greifswald, Germany
Site Reference ID/Investigator# 45025
🇩🇪Hamburg, Germany
Site Reference ID/Investigator# 45027
🇩🇪Heidelberg, Germany
Site Reference ID/Investigator# 45024
🇩🇪Munich, Germany
Site Reference ID/Investigator# 45126
🇭🇺Bekescsaba, Hungary
Site Reference ID/Investigator# 45121
🇭🇺Budaors, Hungary
Site Reference ID/Investigator# 45127
🇭🇺Dunaujvaros, Hungary
Site Reference ID/Investigator# 45115
🇭🇺Gyula, Hungary
Scroll for more (5 remaining)Site Reference ID/Investigator# 45022🇧🇬Ruse, Bulgaria